Principal Health News
Medical Library
Cool Tools
Fitness & Nutrition
Women's Health
Men's Health
Pregnancy
Children's Health
Alternative Health
Lifestyle & Wellness
Ills & Conditions
Health After 60
Work & Health
Dental Health
Self-Care Centers
Brought to you by CVS Caremark

About This Site

Registration

FAQ

Contact Us

Privacy

Terms of Use

Site Awards
You are here: Home > Ills & Conditions > Laxatives


Laxatives


Related topics:
•  Stomach & Digestive Problems

Samuel D. Uretsky PharmD

Below:
Definition
Purpose
Description
Precautions
Key Terms
Resources


-  Definition

Laxatives are products that promote bowel movements.

-  Purpose

Laxatives are used to treat constipation-the passage of small amounts of hard, dry stools, usually fewer than three times a week. Before recommending use of laxatives, differential diagnosis should be performed. Prolonged constipation may be evidence of a significant problem, such as localized peritonitis or diverticulitis. Complaints of constipation may be associated with obsessive-compulsive disorder. Use of laxatives should be avoided in these cases. Patients should be aware that patterns of defecation are highly variable, and may vary from two to three times daily to two to three times weekly.

Laxatives may also be used prophylacticly for patients, such as those recovering from a myocardial infarction or those who have had recent surgery, who should not strain during defecation.

-  Description

Laxatives may be grouped by mechanism of action.

Saline cathartics include dibasic sodium phosphate (Phospo-Soda), magnesium citrate, magnesium hydroxide (milk of magnesia), magnesium sulfate (Epsom salts), sodium biphosphate, and others. They act by attracting and holding water in the intestinal lumen, and may produce a watery stool. Magnesium sulfate is the most potent of the laxatives in this group.

Stimulant and irritant laxatives increase the peristaltic movement of the intestine. Examples include cascara and bisadocyl (Dulcolax.) Castor oil works in a similar fashion.

Bulk producing laxatives increase the volume of the stool, and will both soften the stool and stimulate intestinal motility. Psyillium (Metamucil, Konsil) and methylcellulose (Citrucel) are examples of this type. The overall effect is similar to that of eating high-fiber foods, and this class of laxative is most suitable for regular use.

Docusate (Colace) is the only representative example of the stool softener class. It holds water within the fecal mass, providing a larger, softer stool. Docusate has no effect on acute constipation, since it must be present before the fecal mass forms to have any effect, but may be useful for prevention of constipation in patients with recurrent problems, or those who are about to take a constipating drug, such as narcotic analgesics.

Mineral oil is an emollient laxative. It acts by retarding intestinal absorption of fecal water, thereby softening the stool.

The hyperosmotic laxatives are glycerin and lactulose (Chronulac, Duphalac), both of which act by holding water within the intestine. Lactulose may also increase peristaltic action of the intestine.


Recommended dosage

See specific products.

-  Precautions

Short term use of laxatives is generally safe except in appendicitis, fecal impaction, or intestinal obstruction. Lactulose is composed of two sugar molecules; galactose and fructose, and should not be administered to patients who require a low galactose diet.

Chronic use of laxatives may result in fluid and electrolyte imbalances, steatorrhea, osteomalacia, diarrhea, cathartic colon, and liver disease. Excessive intake of mineral oil may cause impaired absorption of oil soluble vitamins, particularly A and D. Excessive use of magnesium salts may cause hypermanesemia.

Lactulose and magnesium sulfate are pregnancy category B. Casanthranol, cascara sagrada, danthron, docusate sodium, docusate calcium, docusate potassium, mineral oil and senna are category C. Casanthranol, cascara sagrada and danthron are excreted in breast milk, resulting in a potential increased incidence of diarrhea in the nursing infant.


Interactions

Mineral oil and docusate should not be used in combination. Docusate is an emulsifying agent which will increase the absorption of mineral oil.

Bisacodyl tablets are enteric coated, and so should not be used in combination with antacids. The antacids will cause premature rupture of the enteric coating.

-   Key Terms:

Carbohydrates

Compounds, such as cellulose, sugar, and starch, that contain only carbon, hydrogen, and oxygen, and are a major part of the diets of people and other animals.

Cathartic colon

A poorly functioning colon, resulting from the chronic abuse of stimulant cathartics.

Colon

The large intestine.

Diverticulitis

Inflammation of the part of the intestine known as the diverticulum.

Fiber

Carbohydrate material in food that cannot be digested.

Hyperosmetic

Hypertonic, containing a higher concentration of salts or other dissolved materials than normal tissues.

Osteomalacia

A disease of adults, characterized by softening of the bone. Similar to Rickets which is seen in children.

Pregnancy category

A system of classifying drugs according to their established risks for use during pregnancy. Category A: Controlled human studies have demonstrated no fetal risk. Category B: Animal studies indicate no fetal risk, but no human studies, or adverse effects in animals, but not in well-controlled human studies. Category C: No adequate human or animal studies, or adverse fetal effects in animal studies, but no available human data. Category D: Evidence of fetal risk, but benefits outweigh risks. Category X: Evidence of fetal risk. Risks outweigh any benefits.

Steatorrhea

An excess of fat in the stool.

Stool

The solid waste that is left after food is digested. Stool forms in the intestines and passes out of the body through the anus.


-   Resources:


Periodicals

  • "Constipation, Laxatives and Dietary Fiber." HealthTips (April 1993): 9.
  • "Overuse Hazardous: Laxatives Rarely Needed." (Includes related article on types of laxatives.) FDA Consumer (April 1991): 33.

Organizations

  • National Digestive Diseases Information Clearinghouse. 2 Information Way, Bethesda, MD 20892-3570. nddic@info.niddk.nih.gov. http://www.niddk.nih.gov/Brochures/NDDIC.htm.

Last updated July 14, 1999
Copyright 2003. The Thomson Corporation. All rights reserved.


Or Find More On:

Back to top of page

  -

Home | Medical Library | Cool Tools | Fitness & Nutrition | Women's Health
Men's Health | Pregnancy | Children's Health | Alternative Health | Lifestyle & Wellness
Ills & Conditions | Health After 60 | Work & Health | Dental Health | Self-Care Centers

About Principal Health News | Editorial Guidelines | Registration | FAQ | Contact Us | Privacy

Copyright© 2002- Principal Financial Services, Inc. Terms of Use.

We subscribe to the HONcode principles of the Health On the Net Foundation URAC Health Web Site Accreditation Seal